In this study, we demonstrated inhibition of myeloid differentiation in Jak2 V617F–transplanted mice mice but not in wild-type mice, indicating the effectiveness and safety of α-KG supplementation in the MPN setting. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.